Department of Neurology Archives
How arterial “stiffness” may impair cognition
Jan. 24, 2023—New findings from Vanderbilt neurologists suggest that cardiovascular disease may increase the spaces surrounding blood vessels in the brain and lead to cognitive decline.
Federally funded studies into treatment for chronic conditions overlook efficacy in adults with autism, analysis finds
Jan. 13, 2023—Physical health disparity conditions in autistic adults have not been the focus of any research funded by the U.S. National Institutes of Health (NIH) in the last four decades, an analysis of a federal database found.
Early effects of Huntington disease
Jan. 6, 2023—Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials.
VUMC receives national certification for Parkinson’s disease care
Dec. 1, 2022—Vanderbilt University Medical Center recently became the nation’s second health care organization to receive The Joint Commission’s Gold Seal of Approval for Parkinson’s Disease Certification.
Study examines impulsiveness in Parkinson’s disease
Nov. 17, 2022—Vanderbilt researchers are studying aspects of dopamine release and its regulation in Parkinson’s patients with and without impulsive-compulsive behaviors.
Kennedy Center seeks participants for disabilities research learning sessions
Nov. 10, 2022—In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.
Alzheimer’s risk factor and cognition
Nov. 8, 2022—Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.
VUMC implants first patient in NAUTILUS study for treatment of idiopathic generalized epilepsy
Oct. 18, 2022—A Vanderbilt patient with idiopathic generalized epilepsy is now the first to receive neuromodular stimulation of the brain to see if it can help with seizures.
Gene tied to childhood epilepsy
Oct. 6, 2022—Data drawn from four unrelated patients with a childhood epilepsy syndrome — and from in vitro and in vivo studies — link novel variants in a GABA transporter gene to seizure activity, Vanderbilt researchers reported.
VWCH adds epilepsy monitoring unit, onsite neurologist
Oct. 6, 2022—Vanderbilt Wilson County Hospital has added an epilepsy monitoring unit (EMU), with a neurologist onsite seeing patients in the hospital.
A speedier treatment for depression?
Jul. 11, 2022—Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.
New Clinician Spotlight: Shailee Shah
May. 11, 2022—Shailee Shah, MD, MS, has joined Vanderbilt University Medical Center as an assistant professor in the Division of Neuroimmunology within the Department of Neurology.
